Atlas FDA

TRUFILL n-BCA Liquid Embolic System

FDA premarket approval P990040/S030 · decided 2023-02-28

Approval details

PMA number
P990040
Supplement
S030
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
TRUFILL n-BCA Liquid Embolic System
Generic name
tissue adhesive for use in embolization of brain arteriovenous malformations
Applicant
Cerenovus, Inc.
Date received
2022-11-17
Decision date
2023-02-28
Days to decision
103 days
Decision code
APPR
Product code
KGG
Advisory committee
Neurology
Expedited review
No
Location
Miami, FL
Statement
Approval for new manufacturing sites located at: 1) Steris Isomedix Services, 1175 Isuzu Parkway, Grand Prairie, Texas, 75050; 2) Steris Isomedix Services, 7685 St. Andrews Avenue, San Diego, California, 92154; and 3) Sterigenics, 2400 Airport Road, Santa Teresa, New Mexico, 88008. These manufacturing sites will be performing sterilization of the TRUFILL n-BCA Liquid Embolic System.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CEREGLIDE 71 Catheter System; Cerenovus Aspiration Tubing Set (K251828)Cerenovus, Inc.2025-08-22
CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter; Cerenovus Aspiration Tubing Set (K241221)Cerenovus, Inc.2024-10-16
CEREGLIDE 42 Intermediate Catheter; CEREGLIDE 57 Intermediate Catheter (K241244)Cerenovus, Inc.2024-10-16
CEREGLIDE 92 Catheter System (K233982)Cerenovus, Inc.2024-05-09
Cerenovus Large Bore Catheter; Cerenovus Aspiration Tubing Set (K233988)Cerenovus, Inc.2024-01-17
CEREGLIDE 92 Intermediate Catheter (K230726)Cerenovus, Inc.2023-11-29
CEREGLIDE 71 Intermediate Catheter; Cerenovus Aspiration Tubing Set (K221934)Cerenovus, Inc.2023-03-09
CEREGLIDE 71 Intermediate Catheter (K221930)Cerenovus, Inc.2023-03-09